Integral Health Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100,000
| Closed | -$2.06M | – | 90 |
|
|
2024
Q3 | $2.06M | Buy |
+100,000
| New | +$2.06M | 0.23% | 57 |
|
|
2023
Q3 | – | Sell |
-206,000
| Closed | -$8.4M | – | 80 |
|
|
2023
Q2 | $8.4M | Buy |
+206,000
| New | +$8.4M | 1.04% | 39 |
|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$5.23M | – | 80 |
|
|
2022
Q4 | $5.23M | Buy |
150,000
+25,000
| +20% | +$872K | 1.1% | 33 |
|
|
2022
Q3 | $7M | Buy |
125,000
+41,505
| +50% | +$2.32M | 1.36% | 29 |
|
|
2022
Q2 | $4.32M | Buy |
83,495
+33,495
| +67% | +$1.73M | 0.89% | 39 |
|
|
2022
Q1 | $3.63M | Hold |
50,000
| – | – | 0.95% | 37 |
|
|
2021
Q4 | $5.91M | Hold |
50,000
| – | – | 1.64% | 24 |
|
|
2021
Q3 | $6.71M | Buy |
50,000
+20,000
| +67% | +$2.68M | 1.93% | 16 |
|
|
2021
Q2 | $4.86M | Sell |
30,000
-140,000
| -82% | -$22.7M | 1.34% | 30 |
|
|
2021
Q1 | $13.6M | Buy |
170,000
+110,000
| +183% | +$8.83M | 3.9% | 5 |
|
|
2020
Q4 | $3.26M | Buy |
+60,000
| New | +$3.26M | 0.97% | 36 |
|